Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis : Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
This study aims to characterize patients with adulthood-onset bilateral sensorineural hearing loss not due to any underlying medical condition (likely due to a genetic cause) and to assess the evolution of hearing impairment of those carrying mutations in GJB2 gene.Patients who present with adulthood-onset bilateral sensorineural hearing loss will be screened for the presence of mutation involved in hearing impairment. Patients with GJB2 mutations will be proposed to continue in a follow-up period..
Medienart: |
Klinische Studie |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
ClinicalTrials.gov - (2024) vom: 09. Apr. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
610 |
---|
Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: April 9, 2024, Last downloaded: ClinicalTrials.gov processed this data on April 17, 2024, Last updated: April 17, 2024 |
---|
Study ID: |
NCT06354010 |
---|---|
Veröffentlichungen zur Studie: |
|
fisyears: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
CTG009670157 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | CTG009670157 | ||
003 | DE-627 | ||
005 | 20240417010504.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240410s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)CTG009670157 | ||
035 | |a (UBBS_Klinische_Studien)NCT06354010 | ||
035 | |a (UBBS_Klinische_Studien)SENS-NH02 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis |b Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: April 9, 2024, Last downloaded: ClinicalTrials.gov processed this data on April 17, 2024, Last updated: April 17, 2024 | ||
520 | |a This study aims to characterize patients with adulthood-onset bilateral sensorineural hearing loss not due to any underlying medical condition (likely due to a genetic cause) and to assess the evolution of hearing impairment of those carrying mutations in GJB2 gene.Patients who present with adulthood-onset bilateral sensorineural hearing loss will be screened for the presence of mutation involved in hearing impairment. Patients with GJB2 mutations will be proposed to continue in a follow-up period. | ||
650 | 2 | |a Hearing Loss | |
650 | 2 | |a Deafness | |
650 | 2 | |a Hearing Loss, Sensorineural | |
650 | 2 | |a Hearing Loss, Bilateral | |
650 | 2 | |a Presbycusis | |
650 | 4 | |a Study Type: Observational | |
650 | 4 | |a Recruitment Status: Not yet recruiting | |
650 | 4 | |a 610 | |
773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2024) vom: 09. Apr. |
773 | 1 | 8 | |g year:2024 |g day:09 |g month:04 |
856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT06354010 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_CTG | ||
951 | |a AR | ||
952 | |j 2024 |b 09 |c 04 |